181 related articles for article (PubMed ID: 11328791)
1. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans.
Sakamoto I; Igarashi M; Kimura K; Takagi A; Miwa T; Koga Y
J Antimicrob Chemother; 2001 May; 47(5):709-10. PubMed ID: 11328791
[TBL] [Abstract][Full Text] [Related]
2. The Ameliorating Effect of Lactobacillus gasseri OLL2716 on Functional Dyspepsia in Helicobacter pylori-Uninfected Individuals: A Randomized Controlled Study.
Ohtsu T; Takagi A; Uemura N; Inoue K; Sekino H; Kawashima A; Uchida M; Koga Y
Digestion; 2017; 96(2):92-102. PubMed ID: 28768250
[TBL] [Abstract][Full Text] [Related]
3. Detection of Lactobacillus gasseri OLL2716 strain administered with yogurt drink in gastric mucus layer in humans.
Fujimura S; Kato S; Oda M; Miyahara M; Ito Y; Kimura K; Kawamura T; Ohnuma M; Tateno H; Watanabe A
Lett Appl Microbiol; 2006 Nov; 43(5):578-81. PubMed ID: 17032235
[TBL] [Abstract][Full Text] [Related]
4. Suppression of Helicobacter pylori-induced interleukin-8 production in vitro and within the gastric mucosa by a live Lactobacillus strain.
Tamura A; Kumai H; Nakamichi N; Sugiyama T; Deguchi R; Takagi A; Koga Y
J Gastroenterol Hepatol; 2006 Sep; 21(9):1399-406. PubMed ID: 16911683
[TBL] [Abstract][Full Text] [Related]
5. Long-term administration of probiotics to asymptomatic pre-school children for either the eradication or the prevention of Helicobacter pylori infection.
Boonyaritichaikij S; Kuwabara K; Nagano J; Kobayashi K; Koga Y
Helicobacter; 2009 Jun; 14(3):202-7. PubMed ID: 19702850
[TBL] [Abstract][Full Text] [Related]
6. Effects of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in children.
Shimizu T; Haruna H; Hisada K; Yamashiro Y
J Antimicrob Chemother; 2002 Oct; 50(4):617-8. PubMed ID: 12356815
[No Abstract] [Full Text] [Related]
7. Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.
Leja M; Lapina S; Polaka I; Rudzite D; Vilkoite I; Daugule I; Belkovets A; Pimanov S; Makarenko J; Tolmanis I; Lejnieks A; Boka V; Rumba-Rozenfelde I; Vikmanis U
Medicina (Kaunas); 2014; 50(1):8-13. PubMed ID: 25060199
[TBL] [Abstract][Full Text] [Related]
8. Yogurt containing Lactobacillus gasseri OLL 2716 (LG21 yogurt) accelerated the healing of acetic acid-induced gastric ulcer in rats.
Uchida M; Shimizu K; Kurakazu K
Biosci Biotechnol Biochem; 2010; 74(9):1891-4. PubMed ID: 20834166
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio.
Du Y; Agnew A; Ye XP; Robinson PA; Forman D; Crabtree JE
Microbes Infect; 2006 Jan; 8(1):52-60. PubMed ID: 16260169
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of Helicobacter pylori infection on serum pepsinogens.
Kikuchi S; Kurosawa M; Sakiyama T; Tenjin H; Miki K; Wada O; Inaba Y
Jpn J Cancer Res; 2000 May; 91(5):471-6. PubMed ID: 10835490
[TBL] [Abstract][Full Text] [Related]
11. Yogurt containing Lactobacillus gasseri OLL2716 exerts gastroprotective action against [correction of agaisnt] acute gastric lesion and antral ulcer in rats.
Uchida M; Kurakazu K
J Pharmacol Sci; 2004 Sep; 96(1):84-90. PubMed ID: 15359087
[TBL] [Abstract][Full Text] [Related]
12. Probiotics-containing yogurts suppress Helicobacter pylori load and modify immune response and intestinal microbiota in the Helicobacter pylori-infected children.
Yang YJ; Sheu BS
Helicobacter; 2012 Aug; 17(4):297-304. PubMed ID: 22759330
[TBL] [Abstract][Full Text] [Related]
13. Probiotic (yogurt) containing Lactobacillus gasseri OLL2716 is effective for preventing Candida albicans-induced mucosal inflammation and proliferation in the forestomach of diabetic rats.
Terayama Y; Matsuura T; Uchida M; Narama I; Ozaki K
Histol Histopathol; 2016 Jun; 31(6):689-97. PubMed ID: 26691696
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
15. A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication.
Osumi H; Fujisaki J; Suganuma T; Horiuchi Y; Omae M; Yoshio T; Ishiyama A; Tsuchida T; Miki K
PLoS One; 2017; 12(8):e0183980. PubMed ID: 28854276
[TBL] [Abstract][Full Text] [Related]
16. Influences of Helicobacter pylori on serum pepsinogen concentrations in dialysis patients.
Tamura H; Tokushima H; Murakawa M; Matsumura O; Itoyama S; Mitarai T; Isoda K
Nephrol Dial Transplant; 1999 Jan; 14(1):113-7. PubMed ID: 10052488
[TBL] [Abstract][Full Text] [Related]
17. The effect of probiotics on gastric mucosal permeability in humans administered with aspirin.
Akama F; Nishino R; Makino S; Kobayashi K; Kamikaseda K; Nagano J; Koga Y
Scand J Gastroenterol; 2011 Jul; 46(7-8):831-6. PubMed ID: 21492054
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori infection, serum pepsinogens, and pediatric abdominal pain: a pilot study.
Kassem E; Naamna M; Mawassy K; Beer-Davidson G; Muhsen K
Eur J Pediatr; 2017 Aug; 176(8):1099-1105. PubMed ID: 28681188
[TBL] [Abstract][Full Text] [Related]
19. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori.
Wang KY; Li SN; Liu CS; Perng DS; Su YC; Wu DC; Jan CM; Lai CH; Wang TN; Wang WM
Am J Clin Nutr; 2004 Sep; 80(3):737-41. PubMed ID: 15321816
[TBL] [Abstract][Full Text] [Related]
20. Lactobacilli for the management of Helicobacter pylori.
Alsahli M; Michetti P
Nutrition; 2001 Mar; 17(3):268-9. PubMed ID: 11312076
[No Abstract] [Full Text] [Related]
[Next] [New Search]
